Qube Research & Technologies (QRT)
XFOR icon

Qube Research & Technologies (QRT)’s X4 Pharmaceuticals XFOR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-218,954
Closed -$904K – 4173
2026
Q1 		$904K Buy
218,954
+151,207
+223% +$566K ﹤0.01% 2540
2025
Q4 		$271K Buy
+67,747
New +$246K ﹤0.01% 2978

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s XFOR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of X4 Pharmaceuticals (XFOR) in Q2 2026, closing a stake of 218,954 shares — an estimated $904K sold.

Qube Research & Technologies (QRT) first reported a position in XFOR in Q4 2025 and held it in 2 quarters. The position peaked at $904K in Q1 2026. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining X4 Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 218,954 X4 Pharmaceuticals shares in Q2 2026, an estimated $904K.
  • Qube Research & Technologies (QRT) first reported a position in X4 Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s X4 Pharmaceuticals position peaked at $904K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.